Market Research Logo

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2018 Update

Summary

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regenerative orthopedics products, advanced wound care devices, anti-adhesion gels, viscoelastic ophthalmic products, dental bone grafting adjuncts and joint dysfunction management fluids for horses. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Anika has research and manufacturing facilities in Bedford, Massachusetts. The company offers its products through distributors in the Americas, Europe, the Middle East, and Asia. Anika is headquartered in Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Anika Therapeutics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Anika Therapeutics Inc Company Overview
Anika Therapeutics Inc Company Snapshot
Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
Anika Therapeutics Inc – Pipeline Analysis Overview
Business Description
Anika Therapeutics Inc - Key Facts
Anika Therapeutics Inc - Major Products and Services
Anika Therapeutics Inc Pipeline Products by Development Stage
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status
Anika Therapeutics Inc Pipeline Products Overview
Cingal
Cingal Product Overview
Drug Delivery System
Drug Delivery System Product Overview
Hemostatic Patch
Hemostatic Patch Product Overview
HYAFF - Rotator Cuff Repair
HYAFF - Rotator Cuff Repair Product Overview
HYAFF Barrier Film
HYAFF Barrier Film Product Overview
HYAFF Gel
HYAFF Gel Product Overview
HYAFF Mesh
HYAFF Mesh Product Overview
Hyalobone
Hyalobone Product Overview
Hyalofast
Hyalofast Product Overview
Hyalofast Clinical Trial
Hyaloglide
Hyaloglide Product Overview
Hyalograft C Autograft
Hyalograft C Autograft Product Overview
Hyalonect
Hyalonect Product Overview
Hyaluronic Acid - Synovial Joints
Hyaluronic Acid - Synovial Joints Product Overview
MONOVISC
MONOVISC Product Overview
MONOVISC - Hip
MONOVISC - Hip Product Overview
MONOVISC - Hip Clinical Trial
Next Generation ELEVESS Dermal Filler
Next Generation ELEVESS Dermal Filler Product Overview
ORTHOVISC-T
ORTHOVISC-T Product Overview
SCS 17-01
SCS 17-01 Product Overview
Anika Therapeutics Inc - Key Competitors
Anika Therapeutics Inc - Key Employees
Anika Therapeutics Inc - Key Employee Biographies
Anika Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Anika Therapeutics Inc, Recent Developments
Jun 19, 2018: Anika Therapeutics Announces Top-Line Results from CINGAL 16-02 Clinical Trial in Knee Osteoarthritis
May 08, 2018: Anika to Showcase Commercial and Pipeline Portfolio at 18th Bi-Annual European Society for Sports Traumatology, Knee Surgery and Arthroscopy Congress
May 02, 2018: Anika Reports First Quarter 2018 Financial Results
Apr 24, 2018: Amplify What’s Possible: Medline to Highlight Holistic Approach to Wound Care and Skin Health at Symposium on Advanced Wound Care
Apr 06, 2018: Anika Announces Plans to Showcase HYALOFAST Hyaluronic Acid-Based Scaffold at the 2018 World Congress of the International Cartilage Repair Society
Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And Director
Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results
Dec 27, 2017: Anika Announces FDA 510(k) Clearance for Its Injectable HA-Based Bone Repair Treatment
Oct 25, 2017: Anika Reports Third Quarter 2017 Financial Results
Oct 23, 2017: Anika Announces the Forthcoming Appointment of Thomas M. Finnerty as Chief Human Resources Officer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
Anika Therapeutics Inc Pipeline Products by Equipment Type
Anika Therapeutics Inc Pipeline Products by Indication
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status
Anika Therapeutics Inc, Key Facts
Anika Therapeutics Inc, Major Products and Services
Anika Therapeutics Inc Number of Pipeline Products by Development Stage
Anika Therapeutics Inc Pipeline Products Summary by Development Stage
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status
Anika Therapeutics Inc Ongoing Clinical Trials Summary
Cingal - Product Status
Cingal - Product Description
Drug Delivery System - Product Status
Drug Delivery System - Product Description
Hemostatic Patch - Product Status
Hemostatic Patch - Product Description
HYAFF - Rotator Cuff Repair - Product Status
HYAFF - Rotator Cuff Repair - Product Description
HYAFF Barrier Film - Product Status
HYAFF Barrier Film - Product Description
HYAFF Gel - Product Status
HYAFF Gel - Product Description
HYAFF Mesh - Product Status
HYAFF Mesh - Product Description
Hyalobone - Product Status
Hyalobone - Product Description
Hyalofast - Product Status
Hyalofast - Product Description
Hyalofast - A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast with BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control
Hyaloglide - Product Status
Hyaloglide - Product Description
Hyalograft C Autograft - Product Status
Hyalograft C Autograft - Product Description
Hyalonect - Product Status
Hyalonect - Product Description
Hyaluronic Acid - Synovial Joints - Product Status
Hyaluronic Acid - Synovial Joints - Product Description
MONOVISC - Product Status
MONOVISC - Product Description
MONOVISC - Hip - Product Status
MONOVISC - Hip - Product Description
MONOVISC - Hip - Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip
Next Generation ELEVESS Dermal Filler - Product Status
Next Generation ELEVESS Dermal Filler - Product Description
ORTHOVISC-T - Product Status
ORTHOVISC-T - Product Description
SCS 17-01 - Product Status
SCS 17-01 - Product Description
Anika Therapeutics Inc, Key Employees
Anika Therapeutics Inc, Key Employee Biographies
Anika Therapeutics Inc, Subsidiaries
Glossary
List of Figures
Anika Therapeutics Inc Pipeline Products by Equipment Type
Anika Therapeutics Inc Pipeline Products by Development Stage
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report